Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2019-03-18
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Therefore, as a first step, investigators decided to perform a validation clinical study to verify the diagnostic accuracy of duplex ultrasonography of the venous system for CRT screening performed by a general nurse.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reliability of Duplex Ultrasound for Diagnosis of Deep Vein Thrombosis Performed by Nurses
NCT04483193
Daily Ultrasound-screening for CVC-related Thrombosis
NCT03327376
Deep Venous Thrombosis Screening in the ICU by Nurses
NCT03707665
Thrombotic Complications After Central Venous Catheterization
NCT04302376
Catheter Associated Asymptomatic Thrombosis in Intensive Care Unit
NCT04503135
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Investigators:
1. General nurses - trained and able to perform duplex ultrasonography examination of venous circulation
2. Doctors - experienced specialists in intensive care or urgent medicine
Every patient with central venous catheter enrolled in clinical study is examined with duplex ultrasonography within 24 hours by both investigators, doctor and nurse. Each examination includes ultrasonography of a whole vena cava venous system with central venous catheter, bilaterally. Results of both examinations are blinded until the end of study, with one exception. In case of positive result - catheter related thrombosis is present, investigator ( nurse )informs patients attending physician.
Results of investigations are recorded in Investigation Form with some other routine medical data.
Timetable:
18.3.2019 - 30.6.2020: Enrolling, collection of data 1.7.2020 - 30.9.2020: Finalization od database, statistic analysis 1.10.2020 - 31.1.2021: Preparation of publications 1.2. 2021 - 31.12.2021: Result presentation
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Duplex ultrasonography
Ultrasound examination of whole vena cava venous system with central venous catheter inserted, using duplex US method to detect catheter related thrombosis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* consent of a patient
Exclusion Criteria
* unfavorable local findings - inflammation of skin, excoriation etc.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Masaryk Hospital Krajská zdravotní a.s.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Barbora Pakostová, M.D.
Medical doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barbora Pakostová, M.D.
Role: PRINCIPAL_INVESTIGATOR
Krajská zdravotní a.s., Masaryk Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinic of anaesthesiology, resuscitaion and perioperative care, Masaryk Hospital,
Ústí nad Labem, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
258/40
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.